Death · chronic non‐hypovolaemic hypotonic hyponatraemia
It is very uncertain whether vasopressin receptor antagonists changes death compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Health‐related quality of life ( · chronic non‐hypovolaemic hypotonic hyponatraemia
1 finding from 1 review
Length of hospital stay · chronic non‐hypovolaemic hypotonic hyponatraemia
1 finding from 1 review
Cognitive function · chronic non‐hypovolaemic hypotonic hyponatraemia
1 finding from 1 review
Change from baseline in serum sodium concentration · chronic non‐hypovolaemic hypotonic hyponatraemia
1 finding from 1 review
Serum sodium concentration (response) · chronic non‐hypovolaemic hypotonic hyponatraemia
Vasopressin receptor antagonists probably leads to higher serum sodium concentration (response) compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Rapid sodium increase · chronic non‐hypovolaemic hypotonic hyponatraemia
Vasopressin receptor antagonists probably leads to higher rapid sodium increase compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Death · people with CKD
1 finding from 1 review
MACE · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Progression to ESKD Measured as requiring dialysis treatment in people with CKD · people with CKD
It is very uncertain whether dietary modifications (counselling or dietary change) changes progression to ESKD Measured as requiring dialysis treatment in… compared with control (very low certainty).
1 finding from 1 review
Pain1 Not measured · men and women with end‐stage kidney disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Beck Depression Inventory (BDI); higher score means more depression · men and women with end‐stage kidney disease
1 finding from 1 review
Quality of sleep · men and women with end‐stage kidney disease
1 finding from 1 review
Fatigue · men and women with end‐stage kidney disease
1 finding from 1 review
Serum phosphorus · people with CKD‐MBD
1 finding from 1 review
Serum calcium · people with CKD‐MBD
1 finding from 1 review
Alkaline phosphatase · people with CKD‐MBD
1 finding from 1 review
All‐cause mortality · people with CKD‐MBD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular events · people with CKD‐MBD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fracture · people with CKD‐MBD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found